Keyphrases
Liver
100%
Chemoembolization
100%
Toxicity Profile
100%
Drug-eluting Beads
100%
Transarterial
100%
Clinical Safety
100%
Liver Toxicity
100%
Biliary Injury
100%
Safety Toxicity
100%
Adverse Events
50%
Transarterial Chemoembolization
33%
Drug-eluting Beads Transarterial Chemoembolization (DEB-TACE)
33%
Symptomatic Adverse Events
33%
Low Severity
16%
Hepatic Malignancy
16%
Hepatocellular Carcinoma
16%
Doxorubicin
16%
Clinical Symptoms
16%
Metastatic Disease
16%
Locoregional Therapy
16%
Imaging Data
16%
Inclusion Criteria
16%
Single Institution
16%
Preclinical Imaging
16%
Retrospective Analysis
16%
Clinical Laboratory Data
16%
Small Diameter
16%
Low Incidence
16%
Clinical Follow-up
16%
Logistic Regression Analysis
16%
Imaging Follow-up
16%
Predictive Factors
16%
Irinotecan
16%
National Cancer Institute Common Terminology Criteria for Adverse Events
16%
Day Range
16%
Residual Disease
16%
Tumor Diameter
16%
Hypovascular
16%
Patient Inclusion
16%
Lesion Characteristics
16%
Post-embolization Syndrome
16%
Medicine and Dentistry
Adverse Event
100%
Liver Toxicity
100%
Transcatheter Arterial Chemoembolization
100%
Biliary Injury
100%
Neoplasm
16%
Minimal Residual Disease
16%
Metastatic Carcinoma
16%
Logistic Regression Analysis
16%
Hepatocellular Carcinoma
16%
Irinotecan
16%
Population Research
16%
Malignant Neoplasm
16%
Predictive Factor
16%
Symptom
16%
Cancer
16%
Doxorubicin
16%